Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis

A Vinokurtseva, M Fung, E Ai Li, R Zhang… - Clinical …, 2022 - Taylor & Francis
Purpose Starting in 2019, the Global Initiative for Asthma recommended the use of inhaled
corticosteroids (ICS) as part of reliever combination therapy in patients 12 years of age and …

[HTML][HTML] Inhaled corticosteroid and secondary glaucoma: a meta-analysis of 18 studies

M Ishii, N Horita, M Takeuchi, H Matsumoto… - Allergy, Asthma & …, 2021 - ncbi.nlm.nih.gov
Purpose Guidelines and systematic reviews frequently warn of inhaled corticosteroid (ICS)-
induced glaucoma. However, most of the published studies deny it. Methods We performed …

The effects of intranasal, inhaled and systemic glucocorticoids on intraocular pressure: a literature review

D Wijnants, I Stalmans, E Vandewalle - Journal of Clinical Medicine, 2022 - mdpi.com
Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …

[HTML][HTML] The effect of inhaled steroids on the intraocular pressure

S Shroff, RK Thomas, G D'Souza… - Digital journal of …, 2018 - ncbi.nlm.nih.gov
Background Steroids are known to play a role in the pathogenesis of glaucoma, but little is
known about the effect of inhaled corticosteroids (ICS). The purpose of this study was to …

A randomized controlled trial to determine the effect of inhaled corticosteroid on intraocular pressure in open-angle glaucoma and ocular hypertension: the ICOUGH …

EB Moss, YM Buys, SA Low, D Yuen, Y Jin… - Journal of …, 2017 - journals.lww.com
Purpose: The purpose of this study was to determine the risk of a steroid pressure response
from inhaled corticosteroids. Patients and Methods: This randomized, double-masked …

The relationship of intranasal steroids to intraocular pressure

J Bergmann, MT Witmer, CB Slonim - Current allergy and asthma reports, 2009 - Springer
Intranasal corticosteroids have become a gold standard in therapy for allergic
rhinoconjunctivitis. A direct relationship between topical and systemic corticosteroids and …

[PDF][PDF] Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials

N Ahmadi, K Snidvongs, L Kalish, R Sacks… - …, 2015 - sydneyentclinic.com
Background: Intranasal corticosteroids (INCS) are prescribed for the long-term prophylactic
treatment of inflammatory upper airway conditions. Although some systemic absorption can …

Inhaled corticosteroids and the risk of glaucoma and intraocular hypertension

K Novak-Lauš, S Kukulj, R Iveković… - Acta Clinica …, 2003 - hrcak.srce.hr
Sažetak The aim of this study was to examine whether any correlation exists between long
term use of high doses of inhaled corticosteroids and the occurrence of intraocular …

Inhaled corticosteroids: Ocular safety and the hypothalamic-pituitary-adrenal axis

WW Carr, SJ Szefler - Annals of Allergy, Asthma & Immunology, 2016 - Elsevier
Abstract Background Inhaled corticosteroids (ICSs) effectively deliver corticosteroids to
target sites in the lungs and reduce systemic effects compared with oral corticosteroids, but …

Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study

MW Marcus, RPHM Müskens, WD Ramdas… - Drugs & aging, 2012 - Springer
Background It is largely unknown if corticosteroid-induced open-angle glaucoma (OAG) is
an entity that is limited to a few susceptible individuals or whether it contributes significantly …